We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.16B
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+67.93%
3 Year Est. Return
-39.17%
5 Year Est. Return
-45.89%
10 Year Est. Return
–
AUM
$345M
AUM Growth
-$49.4M
Cap. Flow
-$51.5M
Cap. Flow %
-14.92%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EDIT icon
Editas Medicine
EDIT
+$51.5M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNLI icon
1
Denali Therapeutics
DNLI
$3.67B
$176M 50.92%
8,918,749
– –
MCRB icon
2
Seres Therapeutics
MCRB
$48.1M
$93.1M 26.99%
634,144
– –
SYRS
3
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$41.6M 12.06%
320,444
– –
QTRX icon
4
Quanterix
QTRX
$173M
$34.6M 10.03%
2,030,495
– –
EDIT icon
5
Editas Medicine
EDIT
$399M
– –
-1,674,435
Closed -$51.5M

Similar funds

AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
BI
Bramshill Investments Naples, Florida $1.16B AUM 0.86% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $1.16B AUM 13.88% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
FFP
FourThought Financial Partners Venice, Florida $1.16B AUM 24.95% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Flagship Pioneering's Q1 2018 Portfolio in Review

As of Q1 2018, Flagship Pioneering held 5 positions worth $345M, down 13% from $394M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Flagship Pioneering withdrew a net $51.5M in Q1 2018, closing 1 position. Its most notable exit was Editas Medicine, an estimated $51.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Flagship Pioneering fully exited Editas Medicine in Q1 2018, selling an estimated $51.5M.
  • Flagship Pioneering's ten largest holdings make up 100% of its $345M portfolio in Q1 2018.
  • Flagship Pioneering opened 0 new positions and closed 1 in Q1 2018.
  • Flagship Pioneering's portfolio value fell 13% quarter-over-quarter to $345M.

Based on Flagship Pioneering's 13F filing for Q1 2018, filed 15 May 2018.